Jabs COVID being evaluated for infants as young as six months | TAUT



A COVID-19 vaccine for babies and toddlers is another step closer after Australian regulators confirmed they were evaluating a low dose of Moderna’s Spikevax.

There is currently no approved COVID-19 vaccine for children under four, with children aged five and older being vaccinated by Pfizer.

Spikevax is available for children over six and Moderna Australia has asked the Therapeutic Goods Administration to extend it to younger children.

See also  First neighbor to testify at the Dawson trial

The TGA confirmed on Friday that it was evaluating the use of a low dose of Spikevax, 25 micrograms in 0.25ml, for children aged six months to five years.

This is below the 50 micrograms in 0.25ml measure that are currently used for children aged 6-11.

Spikevax, an mRNA vaccine, uses genetic code to enable the production of the coronavirus spike protein.

See also  Scott Morrison will appeal to empty nests at Coalition campaign launch

Immune cells then recognize the spike protein as foreign and begin to mount an immune response against it.



  • NSW: 10,954 cases, 19 deaths, 1,377 in hospital, 58 in intensive care
  • VIC: 12,160 new cases, 22 deaths, 524 in hospital, 24 in intensive care


Please enter your comment!
Please enter your name here